CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to participate in trial for innovative mapping and pulsed field ablation system

Trial Startmapping and pulsed field ablation systemPositive
AI Analysis

Summary

Texas Cardiac Arrhythmia Institute at St. David's Medical Center became the first U.S. facility to participate in a clinical trial evaluating a next-generation mapping and pulsed field ablation system for cardiac arrhythmia treatment.

Clinical Trial Data

Importance:3/10
Sentiment:
0.30
clinical trialcardiac arrhythmiamedical devicepulsed field ablation
Related Companies

Read the original article

Published by PR Newswire Biotech on September 2, 2026 7:37 AM

Read Original